Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.62 USD | +12.08% | +15.87% | -12.25% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.25% | 2.29B | |
+49.72% | 56.87B | |
+37.15% | 39.72B | |
-5.85% | 39.27B | |
-6.90% | 28.73B | |
+13.40% | 26.21B | |
-15.72% | 19.79B | |
+32.78% | 12.28B | |
+27.88% | 12.23B | |
+0.73% | 12.12B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Intellia Therapeutics, ReCode to Develop Therapies For Cystic Fibrosis